The Weekly Recap 2/21/25: LSI Alumni Achievements Driving Medtech and Healthtech Forward

LSI Alumni medical tech companies had a standout week, securing over $174M in funding, gaining regulatory approvals, and forming key partnerships ahead of LSI USA ‘25 (March 17-21, Dana Point, CA). Highlights include Accelus appointing Jim Fox as VP of U.S. Sales, Approxima raising €7.3M for tricuspid valve technology.

Visit us https://www.lifesciencemarketr....esearch.com/insights

Joe Kiani’s Journey: Fighting for Patients, Innovation, and the Courage to Care

At LSI USA ’25, Joe Kiani abandoned his planned speech and spoke from the heart, reflecting on decades of principled battles for patient-centered innovation. From founding Masimo in a garage to challenging monopolies and launching Willow Labs to reinvent diabetes care, Kiani’s story is one of relentless purpose.

Visit us https://www.lifesciencemarketr....esearch.com/insights

Financing Outlook 1H 2024:
Show Me the Money

Healthcare venture funding is recovering in 2024, with increased investments across Healthtech, Med Device, Biopharma, and Diagnostics. Investor confidence is rising, though challenges like weak exits and valuation concerns remain. Med Device funding surged, and M&A activity gained momentum. While uncertainties persist, experts foresee continued growth, marking a cautiously optimistic outlook for the sector.

Visit us https://www.lifesciencemarketr....esearch.com/insights

Make Your Biggest Decisions Data-Driven

Our specialized in-house team has decades of experience evaluating medtech markets and executing custom projects for emerging companies, corporate strategics, consulting and private equity firms, investment banks, and more. Our syndicated market intelligence platform is built by in-house medtech insiders for global medtech executives, with coverage across all medtech markets in all major domestic and global geographies.

Visit us https://www.lifesciencemarketr....esearch.com/custom-r